111
Lorraine F Meisner: Treatment for tissue degenerative inflammatory disease. Peritain, Barnes & Thornburg, March 3, 1987: US04647453 (59 worldwide citation)

A method and composition for treatment of tissue degenerative inflammatory disease in animals and humans afflicted with such disease or disposed to development thereof is disclosed. The method comprises oral administration of ascorbic acid, a source of biologically available calcium, a precursor or ...


112
Bengt I Axelsson, Ralph L Brattsand, Carl M O Dahlback, Leif A Kallstrom, Jan W Trofast: Liposomes containing steroid esters. Aktiebolaget Draco, Brumbaugh Graves Donohue & Raymond, September 15, 1987: US04693999 (59 worldwide citation)

Pharmaceutical composition for administration primarily to the respiratory tract when treating and controlling anti-inflammatory conditions comprising liposomes in combination with a compound of the formula ##STR1## and R.sup.1 is a saturated or unsaturated, straight or branched alkyl group with 11- ...


113
Robert D Kross, Elliott J Siff: Anti-inflammatory formulations for inflammatory diseases. Alcide Corporation, Seed and Berry, January 24, 1995: US05384134 (59 worldwide citation)

There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lubricating composition that is effective in pr ...


114
Myron J Lover: Use of 4-aminosalicyclic acid as an anti-inflammatory agent. Block Drug Company, Ostrolenk Faber Gerb et al, April 3, 1984: US04440763 (59 worldwide citation)

4-Aminosalicylic acid is used in the treatment of inflammation, e.g., inflammatory bowel disease.


115
Gunther Heimke, Andreas F von Recum, Arun Shanbhag: Pharmaceutically protected percutaneous devices. Clemson University, Dority & Manning, September 25, 1990: US04959054 (59 worldwide citation)

A percutaneous implant device includes a structure for storing a bioreactive agent such as an antimicrobic agent, an anti-inflammatory drug, a growth hormone, and an antifungal drug. The structure can take the form of a container or a solid solution. The percutaneous device has a conduit, and the st ...


116
Sloan Kenneth B, Little Roy: Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them.. Merck & Co, November 4, 1981: EP0039051-A2 (59 worldwide citation)

Novel prodrug forms of known non-steroidai anti-inflammatory agents and a process for preparing them are disclosed, said prodrugs having the structural formula wherein R-@- is the acyl residue of a non-steroidal anti-inflammatory agent containing a carboxylic acid function; R1 and R2 each represent ...


117
David J Vachon, John R Helland: Coated implantable stimulation electrode and lead. Siemens Pacesetter, Malcolm J Romano, June 28, 1994: US05324324 (58 worldwide citation)

An implantable stimulation lead having an anti-inflammatory coating on the exposed surface area of the distal tip electrode. The coating is a semi-viscous or gelatinous material having the ability to absorb physiological fluids to provide electrical conductivity through the coating. The coating pref ...


118
Charles H Mitch, Harlan E Shannon: Composition for treating pain. Eli Lilly and Company, David M Stemerick, Arleen Palmberg, MaCharri Vorndran Jones, December 7, 1999: US05998434 (58 worldwide citation)

The present invention provides a composition and method for treating pain using Selected Muscarinic Compounds and one or more compounds selected from the group consisting of Nonsteroidal Anti-inflammatory drugs, acetaminophen, opioids, and alpha-adrenergic compounds.


119
Ronald Brown Miller, Stephen Gordon Douglas, Allan John Miller: Synergistic composition of codine and ibuprofen to treat arthritis. Euro Celtique, Davidson Davidson & Kappel, June 1, 1999: US05908848 (58 worldwide citation)

The invention relates to the use of a non-steroidal anti-inflammatory drug together with an opioid analgesic in the manufacture of a medicament for the treatment of arthritis.


120
Sepetov Nikolai, Zhang Chao, Gschwend Hienz, Kunkel Eric J: Anti-inflammatory pyrazolopyrimidines. The Regents Of The University Of California, Bioseek, Shokat Kevan M, Sepetov Nikolai, Zhang Chao, Gschwend Hienz, Kunkel Eric J, JENKINS Kenneth E, June 29, 2006: WO/2006/068760 (58 worldwide citation)

The present invention provides anti-inflammatory compounds useful in the treatment of diseases and conditions in which inflammation is involved in disease progression or the manifestation of symptoms of the disease or condition.